Court battle expected over generic Plavix

08/11/2006 | San Diego Union-Tribune

Bristol-Myers Squibb this week is expected to seek an injunction to bar Canadian drugmaker Apotex from selling a generic version of the blood thinner Plavix. Bristol-Myers and its partner Sanofi-Aventis had a deal with Apotex to delay sales of the generic, but that agreement recently fell apart.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT